Celgene
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker CELG
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2019 | Sell | 0 | |
| Q3 2019 | Reduce 10% | 556,435 | 1.0% |
| Q2 2019 | Add 8% | 616,002 | 0.9% |
| Q1 2019 | Reduce 8% | 570,323 | 0.8% |
| Q4 2018 | Add 89% | 617,900 | 0.6% |
| Q2 2018 | Add 45% | 565,173 | 0.6% |
| Q1 2018 | Add 94% | 388,970 | 0.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.